| Kuzo Eye Care Llc | |
|
2820 Whiteford Rd Ste 6, York, PA 17402-7625 | |
| (717) 470-0650 | |
| (717) 470-0655 |
| Full Name | Kuzo Eye Care Llc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 2820 Whiteford Rd Ste 6, York, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184363525 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Melissa M Kuzo |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1124471669 PECOS PAC ID: 8123396009 Enrollment ID: I20170619000116 |
News Archive
In a range of species, females show clear preferences when it comes to the choice of their partner - they decide on the basis of external features like antler size or plumage coloration whether a male will be a good father to her offspring, or whether he will provide them with good genes.
Stem cell researchers at UCLA have generated the first genome-wide mapping of a DNA modification called 5-hydroxymethylcytosine (5hmC) in embryonic stem cells, and discovered that it is predominantly found in genes that are turned on, or active.
The D.C. Department of Health (DOH) has released a study by George Washington University School of Public Health & Health Services (SPHHS) indicating the high levels of marketing by antipsychotic drug manufacturers to Medicaid psychiatrists in the District of Columbia.
Today, the American Medical Group Association submitted a letter to the newly formed Senate Committee on Finance Chronic Care Workgroup outlining policies that would support care for the chronically ill.
Boehringer Ingelheim announced today that the US Food and Drug Administration (FDA) has approved a new indication for MICARDIS® (telmisartan) for the reduction of the risk of myocardial infarction (heart attack), stroke, or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take ACE inhibitors. MICARDIS® is the first treatment in its class to be approved for this indication.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kuzo Eye Care Llc 2820 Whiteford Rd Ste 6, York, PA 17402-7625 Ph: (717) 470-0650 | Kuzo Eye Care Llc 2820 Whiteford Rd Ste 6, York, PA 17402-7625 Ph: (717) 470-0650 |
News Archive
In a range of species, females show clear preferences when it comes to the choice of their partner - they decide on the basis of external features like antler size or plumage coloration whether a male will be a good father to her offspring, or whether he will provide them with good genes.
Stem cell researchers at UCLA have generated the first genome-wide mapping of a DNA modification called 5-hydroxymethylcytosine (5hmC) in embryonic stem cells, and discovered that it is predominantly found in genes that are turned on, or active.
The D.C. Department of Health (DOH) has released a study by George Washington University School of Public Health & Health Services (SPHHS) indicating the high levels of marketing by antipsychotic drug manufacturers to Medicaid psychiatrists in the District of Columbia.
Today, the American Medical Group Association submitted a letter to the newly formed Senate Committee on Finance Chronic Care Workgroup outlining policies that would support care for the chronically ill.
Boehringer Ingelheim announced today that the US Food and Drug Administration (FDA) has approved a new indication for MICARDIS® (telmisartan) for the reduction of the risk of myocardial infarction (heart attack), stroke, or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take ACE inhibitors. MICARDIS® is the first treatment in its class to be approved for this indication.
› Verified 8 days ago
Dr. John Mark Snyder, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1945 Queenswood Drive, York, PA 17403 Phone: 717-846-6900 Fax: 717-854-9728 | |
Dr. Matthew J Link, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 25 Monument Rd, Suite 297, York, PA 17403 Phone: 717-741-6732 Fax: 717-741-6058 | |
Dr. James P. Tuttle And Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2050 E Market St, York, PA 17402 Phone: 717-755-6906 Fax: 717-840-4847 | |
Mrs. Colleen Mary Rae-jenkins, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 25 Monument Rd Ste 297, York, PA 17403 Phone: 717-741-6732 Fax: 717-741-6058 | |
Myeyedr. Optometrist Medicare: Medicare Enrolled Practice Location: 2553 E Market St, York, PA 17402 Phone: 717-757-5632 | |
Eyecare Professionals Optometrist Medicare: Not Enrolled in Medicare Practice Location: 855 N Adams St, York, PA 17404 Phone: 717-843-8993 Fax: 717-848-5217 | |
Dr. Erika Elizabeth Mabus, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 25 Monument Rd, #297, York, PA 17403 Phone: 717-741-6732 |